Macro Dragon WK #21: Inflation Divergence, Central Banks vs. Markets?

Macro 4 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Macro Dragon = Cross-Asset Quasi-Daily Views that could cover anything from tactical positioning, to long-term thematic investments, key events & inflection points in the markets, all with the objective of consistent wealth creation overtime.


(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)

Macro Dragon WK #21: Inflation Divergence, Central Banks vs. Markets?


Top of Mind…

  • TGIM & welcome to WK #21
  • …where in Singapore (similar to other places in Asia, Taiwan, Japan) we have moved towards more restrictions, given concerns on the latest Covid-19 mutation focus, with this strain being believed to have originated in India. We’ve had similar concerns around the UK  Strain & the South African Strain from.
  • Naturally, better that all this is happening in a world where there is a vaccine, than say just 9months ago, when we had no vaccines. Its easier to manufacture a new vaccine for a new Covid strain, than if one had no vaccine.
  • Yet once again, the opening & closing, reopening dance shows that its not a linear path to the light at the end of the tunnel. With that said, KVP firmly believe it’s a question of when, not If. And yes, further restrictions means more fiscal aid has to come through.
  • Worth noting the UK will be ‘opening’ up again today & hopefully that trend will continue, as also Greece & New York get less restrictive.  
  • Last wk’s market infatuation was on the big beat in US inflation at +4.2%a vs +3.6%e, +2.6%p
  • Now know from base effect levels that a big number was possible, yet what likely threw the spanner in the works, was the abysmal -734K miss that we had in the US NFPs from two Fridays back. We also saw China with a strong PPI last wk +6.8%a 6.5%e 4.4%p.
  • The divergence on the inflation narrative between most central banks & the markets continues to play out – granted even within the Market camp, there are differing views.
  • The official Saxo House view is inflation is here & is not transitory, as we have been hearing from the Fed & ECB.
  • From KVP’s side, would just love to see the world without the covid-induced logistics constraints on supply/demand – lot of noise out there. Yet with that said, there will always be pockets of inflation & pockets of deflation, depending on what part of the ecosystem one is focusing on.   
  • Worth noting that UST 1.62% yields are still within the recent trading ranges & gold $1,850 on the other hand continues to break out higher, whilst the crypto complex retraces with BTC $45,000 & ETH $3,300.
  • Lastly, we are still +11.1% YTD on the S&P 500 at 4,173, with the Nasdaq +4.2% YTD at 13,429. Whilst the VIX jumped c. +13% last wk to close at 18.81, the big rally towards the end of the wk took us from the highs of 27.59 (US inflation print Weds).

 

2Q SaxoStrats Outlook

“In a Globe Drowning in Capital, Speculation is Eating the World”


Rest of the Week & Other Reflections

-

Start<>End = Gratitude + Integrity + Vision + Tenacity | Process > Outcome | Sizing > Position.

This is The Way

Namaste,

-KVP

Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide and Product Disclosure Statement to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.
Please click here to view our full disclaimer.